Medidata and Syapse are partnering up to help trial sponsors accelerate clinical research into precision medicine for use in oncology. Syapse software powers precision medicine for nearly 300 US hospitals, while Medidata's cloud-based technology and data analytics systems are used by 18 of the top 25 pharmaceutical firms. The pair hope to build a range of solutions that optimise trial eligibility criteria and make it easier for specialists to identify and enrol patients, said Syapse, president of Medidata.
Medidata and Syapse are partnering up to help trial sponsors accelerate clinical research into precision medicine for use in oncology. Syapse software powers precision medicine for nearly 300 US hospitals, while Medidata's cloud-based technology and data analytics systems are used by 18 of the top 25 pharmaceutical firms. The pair hope to build a range of solutions that optimise trial eligibility criteria and make it easier for specialists to identify and enrol patients, said Glen de Vries, president of Medidata.